Hemodynamic Flow Alteration Devices Market to Hit USD 1.5 Bn by 2031 | Exclusive Report by TMR
Transparency Market Research
Updated 6 min read
Transparency Market Research
Global hemodynamic flow alteration devices market growth driven by the rise in prevalence of disorders such as diabetes, hypertension, and obesity around the world and the increase in geriatric population and diseases associated with old age.
Wilmington, Delaware, United States, March 31, 2023 (GLOBE NEWSWIRE) -- The expert team of analysts at TMR has conducted thorough market research and curated hemodynamic flow alteration devices market report. The report suggests that the industry was valued USD 708.9 Mn in 2022 and is expected to reach USD 1.5 Bn by 2031 at a CAGR of 8.7%.
This exhaustive report contains all-important aspects that influence business development. The parameters include key trends, competitive landscape, market segmentation, regional dynamics, company profiles, and other information regarding the growth trajectory. The deep insights help stakeholders and CXOs to make proper business plans and strategies.
For Insights on Global, Regional, and Country-Level Parameters with Growth Opportunities By 2031 - Download a Sample Report!
Market Snapshot:
Report Coverage
Details
Market Revenue
USD 708.9 Mn in 2022
Estimated Value
USD 1.5 Bn by 2031
Growth Rate
8.7%
Forecast Period
2023–2031
No. of Pages
165 Pages
Market Segmentation
By Type and End-user
Regions Covered
North America, Europe, Asia Pacific, Middle East & Africa, South America
Companies Covered
Boston Scientific Corporation, Medtronic, Edward Lifesciences Corporation, Abbott Laboratories, BIOTRONIK SE & Co. KG, iVascular, Koninklijke Philips N.V., and Terumo Corporation
Hemodynamic flow alteration devices are applied in several treatment procedures for various cardiovascular diseases in order to accelerate blood flow. They facilitate novel procedures that are employed to treat blockages in coronary arteries. However, these devices can cause complications such as infection, blood clots, and bleeding. These restraints can be eliminated through relentless research and development activities, which may eventually boost industry growth.
Surge in lifestyle-related disorders to spur industry growth: Rise in prevalence of lifestyle diseases, including hypertension, obesity, and other chronic and cardiovascular diseases, is accelerating the business progress. Adoption of sedentary lifestyle and increase in work stress have led to a ailments that need proper treatment procedures. Lack of exercise and workload has led to lifestyle diseases such as blood pressure, diabetes, obesity, and hypertension. These ailments, when aggravated, lead to cardiovascular diseases. Therefore, the global business is estimated to witness voluminous growth in the next few years.
Increase in advanced stents procedures to augment market growth: Technological developments in hemodynamic flow alteration equipment through a relentless focus on research and development have led to novel designs and features that are expected to enhance treatment procedures. Integration of AI and robotic-assisted surgery has made treatment procedures more efficient. Stent placement and embolization are carried out with greater precision as a result of these advancements. Other benefits of technology such as reduced recovery span, less hospitalization, and minimally invasive surgical procedures have played a crucial role in providing efficient services. Therefore, the business is expected to experience significant progress during the forecast period.
Key Drivers of Hemodynamic Flow Alteration Devices Market
Embolic protection device category to account for major market share: The embolic protection device segment is expected to exhibit lucrative growth prospects due to the efficiency of these devices to avoid major complications and stroke. These devices regularize the blood flow and avoid blockages. They also eliminate the danger associated with restenosis, which may ultimately lead to business development.
Hospital and clinics segment to witness tremendous growth: The hospital and clinic segment is anticipated to grow rapidly as a result of the increasing application in healthcare industry. Rise in application of hemodynamic flow alteration in medical procedures, including embolization, angioplasty, and stenting, is anticipated to fuel industry dynamics. Additionally, increase in demand for minimally invasive procedures is driving the segment.
North America is estimated to exhibit significant market progress due to the rise in cases of cardiovascular diseases in the region. Concurrently, the region has a full-fledged healthcare infrastructure with advanced treatment procedures. This is estimated to ultimately propel the business scope. Market dynamics of North America involve reimbursement policies from various insurance companies. This is anticipated to contribute to business development.
The market in Asia Pacific is also expected to witness lucrative opportunities due to the increase in geriatric population and high prevalence of cardiovascular disorders in the region. Subsequently, growth in investments in development of healthcare facilities has opened up new opportunities for the global industry.
The global industry is estimated to grow vigorously owing to the efforts taken by the key players to innovate new products with efficient workflow. Incorporation of image-guided procedures for accurate treatment procedures is also creating immense opportunities for global business. Strategic collaborations with mergers, acquisitions, joint ventures, and partnerships have contributed to market expansion. Substantial investments in research and development activities have played a vital role in industry expansion. Developments such as integration with assessment and measurement abilities have created revenue generation opportunities for the global business.
Major participants operating in the global market are:
BIOTRONIK SE & Co. KG
Koninklijke Philips N.V
Boston Scientific Corporation
Edward Lifesciences Corporation
Medtronic
Terumo Corporation
iVascular
Abbot Laboratories
Browse in-depth TOC on Hemodynamic Flow Alteration Devices Market Trends, and Growth Drivers
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
